Advances in psychiatry and nuerology


ISSN 1234-8279

ISSN on-line 2449-9315 

 

As of July 2026, the journal's publisher is Wroclaw Medical University: https://ppn.umw.edu.pl/en/about/.

 

CiteScore 2025: 0.4

MNiSW: 20

Index Copernicus 2023: 90.54

Editorial panel
Submitting and reviewing works online

Archive 1995–2023

2005, volume 21, issue 4
Article

Antidepressants in the treatment of pain syndromes

Farmakoterapia w Psychiatrii i Neurologii, 2005, 4, 329-342
Keywords: antidepressants, pain syndromes
Summary

Antidepressant drugs have been used for many years to treat various pain syndromes. The mechanism of analgesic action is still unclear. The following factors most likely contribute to this effect: interfering with noradrenergic, serotoninergic, dopaminergic, GABA-ergic and opioid systems, adenosine reuptake inhibition, blocking of the NMDA receptor and ion channels. Analgesic action of tricyclic antidepressants (TcA) have been proven. In spite of their improved tolerance, selective serotonin reuptake inhibitors do not appear to be particularly effective in the treatment of pain. Recently, a number of controlled trials with selective serotonin and noradrenaline reuptake inhibitors, such as venlafaxine, milnacipran and duloxetine, suggest that these drugs are as effective in relieving pain as TcA and better tolerated. The analgesic effect of antidepressants seems to be independent of their antidepressant effect.

You have added an item to your cart
Restore password
Shopping cart (0)
No products in your cart
Font size
Contrast
Underlined links